This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Pfizer Corporation, Amgen Fremont Inc.. Active years: 2011-2019.
Location History:
- Cambridge, MA (US) (2016)
- Sandwich, GB (2011 - 2019)
Company Filing History:

Years Active: 2011-2019
Title: Innovations of Nicholas Pullen
Introduction
Nicholas Pullen is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 5 patents to his name, Pullen's work has the potential to impact medical treatments and diagnostics.
Latest Patents
One of Pullen's latest patents focuses on antibodies to MAdCAM. This invention relates to human antibodies and antigen-binding portions that specifically bind to MAdCAM, inhibiting its function. The patent also covers human anti-MAdCAM antibodies, chimeric antibodies, bispecific antibodies, and methods for producing these antibodies. Additionally, it includes gene therapy methods using nucleic acid molecules encoding the immunoglobulin molecules that comprise the human anti-MAdCAM antibodies. Another significant patent involves human antibodies that bind to human MAdCAM, detailing the methods of making and using these antibodies.
Career Highlights
Throughout his career, Nicholas Pullen has worked with prominent companies in the biotechnology sector. He has been associated with Pfizer Corporation and Amgen Fremont Inc., where he contributed to various innovative projects. His expertise in antibody development has positioned him as a valuable asset in the industry.
Collaborations
Pullen has collaborated with notable professionals in his field, including Elizabeth Molloy and Larry L Green. These collaborations have likely enhanced his research and development efforts, leading to successful innovations.
Conclusion
Nicholas Pullen's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work on antibodies has the potential to advance medical science and improve treatment options for various conditions.